Dr. Normand is Director of AIDS Research at the National Institute on Drug Abuse/NIH. As Director, he is responsible for planning, developing, coordinating and integrating all HIV/AIDS research priorities within NIDA and externally. Dr. Normand joined NIDA in 1997, prior to his work at NIDA; he was a Study Director at the National Research Council and the Institute of Medicine of the National Academy of Sciences in Washington, D.C., where he directed the Panel on Needle Exchange and Bleach Distribution Programs, and the Committee on Drug Use in the Workplace.
His earlier professional experience included research positions in both the private and public sectors. He has served as expert witnesses in both domestic and international litigations, served as reviewer for various professional journals and grants review groups (NIH and private foundation), has published in various professional research journals and has spoken at numerous professional meetings on various scientific issues.
Dr. Normand is currently a member of the Technical Workgroup of the Substance Abuse Subcommittee of the Office of the Global AIDS Coordinator (OGAC); and recently served on the HIV Incidence Subcommittee of the Federal HIV/AIDS Interagency Working Group of the Office of National AIDS Policy’s National HIV/AIDS Strategy, January, 2010; member of the International AIDS Society’s Advisory Group for the Strategic Support of Treatment as Prevention (TasP Advisory Group), 2012; and a member 1st, 2nd, and 3rd International HIV Treatment as Prevention Workshop Scientific Advisory Committee, 2011, 2012, 2013.